UAMY Stock Faces Seventh Day In Red As Q1 Earnings Disappoint: Retail Traders Say 'Buy The Fear'

• The company’s Q1 revenue missed the Street estimate. 
• Gross margin plunged to 16% from 34%, driven by higher input costs.
• After March 31, the company secured $12.8 million in grants and raised $48.6 million via equity issuance. 

United States Antimony Corporation (UAMY) is under intense market pressure as the stock declines by more than 5% in Friday’s premarket, extending a punishing streak that is now on track for its seventh consecutive session. 

The company disclosed its fiscal first-quarter (Q1) results on Thursday, revealing a sharp reversal in profitability and a revenue shortfall that spooked investors.

UAMY’s Q1 Performance 

The company generated $6.8 million in revenue, slightly below the $7.0 million recorded a year earlier. Antimony sales declined in volume even as pricing improved, while zeolite revenues also edged lower. Revenue missed the analysts’ consensus estimate of $14.83 million, according to Fiscal AI data. 

Net loss ballooned to $11.3 million from a profit a year earlier. Gross margin dropped to 16% from 34% because costs rose and cheaper ore was not fully used. The company posted a Q1 loss of $0.08 per share. 

Despite the weak quarter, the company reaffirmed its full-year 2026 revenue target of $125 million, expecting stronger contributions in the second half as government-related contracts ramp up. 

“These cost increases were needed, to get the talent, factory, and inventory we need for the expected ramp-up in production for the remainder of this year. We expect these costs to improve with economies of scale as sales increase,” said Rick Isaac, CFO, United States Antimony Corporation.

UAMY’s Capital Inflows

Even with the quarterly loss, the CFO noted the company held about $60.2 million in cash and investments, including U.S. Treasury and equity securities, at the end of the quarter. 

After March 31, the company got $12.8 million in government grants for expansion projects and raised another $48.6 million by issuing shares, improving cash availability but increasing the number of shares.

The company is still expanding its U.S. antimony supply network, with mining in Montana and Alaska and more processing facilities in Montana and Mexico. It expects production to improve in the second half of 2026 as new projects begin operating. 

UAMY Retail Traders View 

On Stocktwits, retail sentiment around the stock changed to ‘neutral’ from ‘bearish’ territory the previous day. With a 320% surge in message volume. 

A user said, “buy the fear and sell the greed,  when additional grants are awarded and sales to the dla comes to fruition, we will be in the teens, they have over 20m in inventory, once that is process the revenues will be much higher, adding on dips.”

Another user said, “you already know there will be Trump administration headlines for more rare earth metals during Midterms… buy when others are fearful.” 

UAMY stock has gained over 90% year-to-date. 

Also See: DAL Leads Airline Stocks In Turbulent Year — But Elon Musk Warns Of Passenger Loss By Picking Amazon Leo Over Starlink

For updates and corrections, email newsroom[at]stocktwits[dot]com.